Ginsenoside Rg4

CAS No. 126223-28-7

Ginsenoside Rg4( —— )

Catalog No. M29152 CAS No. 126223-28-7

Ginsenoside Rg4 is isolated from the leaves of Panax ginseng C. A. Meyer. Ginsenoside Rg4 is a protopanaxatriol type ginsenoside with anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 290 Get Quote
10MG 470 Get Quote
25MG 750 Get Quote
50MG 1008 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ginsenoside Rg4
  • Note
    Research use only, not for human use.
  • Brief Description
    Ginsenoside Rg4 is isolated from the leaves of Panax ginseng C. A. Meyer. Ginsenoside Rg4 is a protopanaxatriol type ginsenoside with anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant properties.
  • Description
    Ginsenoside Rg4 is isolated from the leaves of Panax ginseng C. A. Meyer. Ginsenoside Rg4 is a protopanaxatriol type ginsenoside with anti-septic, anti-diabetic, wound healing, immune-stimulatory, and anti-antioxidant properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    126223-28-7
  • Formula Weight
    767.01
  • Molecular Formula
    C42H70O12
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12[C@H](CC[C@@]1(C)[C@]1(C)C[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C3C(C)(C)[C@H](O)CC[C@]3(C)[C@@]1([H])C[C@@H]2O)C(\C)=C/CC=C(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Apramycin

    An aminoglycoside antibiotic used in veterinary medicine.

  • Rifabutin

    A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.

  • GSK-1322322

    A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.